US Stem Cell Bank now has all 21 Federally Approved Embryonic Stem Cell Lines |
Makes all stem cell lines available for research |
|
Editors published 1/30/2009 6:00:00 AM
|
The National Stem Cell Bank (NSCB) has now acquired all 21 embryonic stem cell lines currently available for Federal funding.
The NSCB is "a repository for the pluripotent stem cell lines listed on the NIH Stem Cell Registry. These cells were derived prior to August 2001 using excess IVF embryos and are therefore eligible for use in federally funded research in the United States. The goal of the National Stem Cell Bank is to grow, characterize and distribute the cell lines listed on the registry, and to provide comprehensive technical support to stem cell researchers around the world."
The NSCB is led by Drs. Derek Hei and James Thomson.
[They] recently received deposits of the last two cell lines from Cellartis AB, a biotechnology company based in Sweden.
The National Institutes of Health established the bank at the WiCell Research Institute in 2005 to obtain, study and distribute the 21 lines to researchers. All six providers of those lines were invited to deposit their cells into the bank after it was established.
|
| |
